Today marks the launch of Global Biosimilars Week 2026, running from 19-24 October, an online, international awareness campaign led by the International Generic and Biosimilar Medicines Association (IGBA). This year’s theme, “Realizing the Global Value of Biosimilars,” aims to expand understanding of the powerful and life-changing impact biosimilar medicines can have for patients, healthcare systems, economies and societies around the world.
IGBA, the International Generic and Biosimilar medicines Association, representing global manufacturers of generic and biosimilar medicines, announced today that Medicines UK has joined IGBA as a new Associate Member.
The International Generic and Biosimilar Medicines Association (IGBA), has appointed Ana Gaunt as its new Secretary General with immediate effect, following the decision of Susana Almeida to step down from the role to pursue other opportunities.
- Constituency Statement: WHO's Executive Board Meeting 158 (February 2026)
- Jim Keon of CGPA Takes Over as IGBA Chair (January 2026)
- Single Global Development of Generic and Biosimilar Medicines: a cornerstone of Patient Access (December 2025)
- The IGBA CEO Advisory Committee: Patient Access, Industry Value, and Global Cooperation in a Reshaping World (December 2025)
